Cell

DYCM POWER ANNOUNCES U.S. SOLAR CELL AND MODULE FACILITY

Retrieved on: 
Tuesday, September 10, 2024

NEW YORK, Sept. 10, 2024 /PRNewswire/ -- DYCM Power, LLC ("DYCM Power"), a joint venture formed by Das & Co., LLC and APC Holdings, LLC, today announced its plans to develop an $800 million solar cell and module manufacturing facility within the United States in partnership with Macquarie Capital. The facility will initially produce 2 GW of cells and modules annually, with a planned expansion up to 6 GW.

Key Points: 
  • Company aims to build one of the largest solar cell and module manufacturing facilities in the U.S.
    NEW YORK, Sept. 10, 2024 /PRNewswire/ -- DYCM Power, LLC ("DYCM Power"), a joint venture formed by Das & Co., LLC and APC Holdings, LLC, today announced its plans to develop an $800 million solar cell and module manufacturing facility within the United States in partnership with Macquarie Capital.
  • DYCM Power's integrated facility will produce advanced TOPCon cells and assemble them into modules, with shipments expected to start in the first half of 2026.
  • Richard Powell, Co-Founder and President of DYCM Power, added, "Our partnership with Macquarie Capital is a defining moment for DYCM Power.
  • "ECM Group is proud to support DYCM Power in securing an innovative and sustainable solar manufacturing supply chain within the United States," said Laurent Pelissier, Chairman of ECM Group.

Children's Hospital of Philadelphia Researchers Report Encouraging First Evidence of Effective New Gene Therapy to Treat Multiple Sulfatase Deficiency

Retrieved on: 
Tuesday, September 10, 2024

PHILADELPHIA, Sept. 9, 2024 /PRNewswire/ -- Researchers from Children's Hospital of Philadelphia (CHOP) tested a preclinical model for an experimental gene therapy designed to treat multiple sulfatase deficiency (MSD), a disorder that affects the brain, lungs, skin, and skeleton with no currently approved treatments. The findings demonstrated several improvements in outcomes, paving the way for future translation into clinical trials. The findings were published today in the journal Molecular Therapy.

Key Points: 
  • PHILADELPHIA, Sept. 9, 2024 /PRNewswire/ -- Researchers from Children's Hospital of Philadelphia (CHOP) tested a preclinical model for an experimental gene therapy designed to treat multiple sulfatase deficiency (MSD), a disorder that affects the brain, lungs, skin, and skeleton with no currently approved treatments.
  • Researchers from CHOP have taken several key approaches toward understanding MSD and developing potential therapies to treat it.
  • "With multiple gene therapy candidates for this disease, we are optimizing the likelihood of really being able to help families."
  • Pham et al, "Hematopoietic stem cell gene therapy improves outcomes in a clinically relevant mouse model of Multiple Sulfatase Deficiency."

Researchers don’t take enough account of variation in biology – doing so could unlock new understanding in science and medicine

Retrieved on: 
Tuesday, September 10, 2024

I believe this pervasive variation, which I call poikilosis, is one of the most important aspects of biology.

Key Points: 
  • I believe this pervasive variation, which I call poikilosis, is one of the most important aspects of biology.
  • Yet it doesn’t receive anywhere near enough attention from scientists and doctors – or worse, it is treated as unwanted noise in experiments and studies.
  • But if scientists were to take much greater account of variation it could lead to new ways of understanding biological systems, and perhaps new ways to treat disease.
  • However, research has shown that when variation in animals used in studies is taken into account, that increases the reproducibility of research.
  • But measurements that account for poikilosis typically demand for higher number of experiments than traditionally made.

Lagom, natural state

  • We can use the term “lagom”, a Swedish concept for just the right amount – not too much or too little – to refer to the natural, balanced state of any system required for it to function normally.
  • When one level enters a non-lagom state, it can affect several other levels, potentially causing damage or impairing the functionality of the system or individual.
  • If it rises to unusually high and harmful levels it enters a non-lagom state.
  • For example, I have developed a model for “biological regulation” (active alteration of the state of a biological system) known as the PLTR model.

Fluence Initiates U.S. Manufacturing of Battery Modules for Energy Storage Products

Retrieved on: 
Tuesday, September 10, 2024

ARLINGTON, Va., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (“Fluence”) (NASDAQ: FLNC), a global market leader delivering intelligent energy storage, operational services, and asset optimization software, today announced the start of domestic production of its battery modules at a facility in Utah.

Key Points: 
  • ARLINGTON, Va., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (“Fluence”) (NASDAQ: FLNC), a global market leader delivering intelligent energy storage, operational services, and asset optimization software, today announced the start of domestic production of its battery modules at a facility in Utah.
  • This marks a key step in Fluence’s strategy to scale module production with domestically sourced components to meet increasing domestic demand for utility-scale energy storage.
  • Fluence’s domestically manufactured battery modules seamlessly integrate with Fluence’s battery management system to deliver industry-leading state of charge, balance, and system health.
  • Additionally, Fluence recently announced an agreement with Excelsior Energy Capital to deploy 2.2 GWh of energy storage projects using domestically manufactured battery systems across the United States, beginning in 2025.

FUJIFILM Cellular Dynamics Introduces Human iPSC-derived Sensory Neurons to Advance Pain Research

Retrieved on: 
Tuesday, September 10, 2024

FUJIFILM Cellular Dynamics will present iCell Sensory Neurons and other key products in its market-leading neuroscience portfolio at the Society for Neuroscience annual conference in Chicago (booth #464) from October 5-9, 2024 and the Annual Pain Therapeutics Summit in Boston from October 28-29, 2024.

Key Points: 
  • FUJIFILM Cellular Dynamics will present iCell Sensory Neurons and other key products in its market-leading neuroscience portfolio at the Society for Neuroscience annual conference in Chicago (booth #464) from October 5-9, 2024 and the Annual Pain Therapeutics Summit in Boston from October 28-29, 2024.
  • Sensory neurons that innervate the skin and internal organs are responsible for relaying sensory information to the central nervous system, including noxious/painful stimuli.
  • The use of highly relevant human neurons promises to significantly improve drug predictability compared to animal models, and provide investigators with better models to improve pain research outcomes.
  • To learn more about FUJIFILM Cellular Dynamics’ iCell Sensory Neurons, visit our website using the specific link: https://www.fujifilmcdi.com/sensory_neurons
    FUJIFILM Cellular Dynamics will present two posters featuring iCell Sensory Neurons at the upcoming Society for Neuroscience 2024 annual conference:

Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H)

Retrieved on: 
Tuesday, September 10, 2024

Cellino Biotech, Inc. today announced that the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, has awarded it up to $25 million in funding to develop an ultra-scalable, autonomous, cassette-based advanced biomanufacturing technology for personalized regenerative medicines.

Key Points: 
  • Cellino Biotech, Inc. today announced that the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, has awarded it up to $25 million in funding to develop an ultra-scalable, autonomous, cassette-based advanced biomanufacturing technology for personalized regenerative medicines.
  • Cellino’s NEBULA (NExt-generation Biomanufacturing ULtra-scalable Approach) project is the first project funded by the Scalable Solutions Mission Office under the ARPA-H Open Broad Agency Announcement.
  • Personalized cells and tissues minimize immune-related complications and improve health equity by obviating the need for a donor match.
  • This effort aligns with ARPA-H’s mission to improve health outcomes for everyone.

StoreDot Accelerates EV adoption: 10-Minute Charging of Large Prismatic Batteries Now a Reality

Retrieved on: 
Tuesday, September 10, 2024

IRVINE, Calif. and HERZLIYA, Israel, Sept. 10, 2024 /PRNewswire/ -- StoreDot, the pioneer in extreme fast charging (XFC) silicon battery technology for electric vehicles (EVs), announces that its prismatic battery cell charges from 10 to 80 percent in just 10 minutes without compromising on the battery's health and range, solving the charging speed challenge. StoreDot's battery addresses the main barrier to mass EV adoption by eliminating charging anxiety and is available for immediate integration by OEMs.

Key Points: 
  • StoreDot's battery addresses the main barrier to mass EV adoption by eliminating charging anxiety and is available for immediate integration by OEMs.
  • Despite halving the charging time compared to other premium fast-charging models, StoreDot's batteries uniquely show no accelerated degradation due to fast charge.
  • "Together, we've taken a giant leap forward in EV battery innovation, offering OEMs our game-changing XFC technology in the prismatic format many prefer.
  • This is a significant step forward in our shared mission to accelerate electric vehicle adoption by addressing one of the most critical challenges – charging time."

StoreDot Accelerates EV adoption: 10-Minute Charging of Large Prismatic Batteries Now a Reality

Retrieved on: 
Tuesday, September 10, 2024

IRVINE, Calif. and HERZLIYA, Israel, Sept. 10, 2024 /PRNewswire/ -- StoreDot, the pioneer in extreme fast charging (XFC) silicon battery technology for electric vehicles (EVs), announces that its prismatic battery cell charges from 10 to 80 percent in just 10 minutes without compromising on the battery's health and range, solving the charging speed challenge. StoreDot's battery addresses the main barrier to mass EV adoption by eliminating charging anxiety and is available for immediate integration by OEMs.

Key Points: 
  • StoreDot's battery addresses the main barrier to mass EV adoption by eliminating charging anxiety and is available for immediate integration by OEMs.
  • Despite halving the charging time compared to other premium fast-charging models, StoreDot's batteries uniquely show no accelerated degradation due to fast charge.
  • "Together, we've taken a giant leap forward in EV battery innovation, offering OEMs our game-changing XFC technology in the prismatic format many prefer.
  • This is a significant step forward in our shared mission to accelerate electric vehicle adoption by addressing one of the most critical challenges – charging time."

Is weight loss as simple as calories in, calories out? In the end, it’s your gut microbes and leftovers that make your calories count

Retrieved on: 
Tuesday, September 10, 2024

From the moment food touches your tongue to the time it leaves your body, your digestive system and gut microbiome work to extract its nutrients.

Key Points: 
  • From the moment food touches your tongue to the time it leaves your body, your digestive system and gut microbiome work to extract its nutrients.
  • Enzymes in your mouth, stomach and small intestine break down food for absorption, while microbes in your large intestine digest the leftovers.
  • “Calories in, calories out” refers to the concept that weight change is determined by the balance between the calories you consume and calories you expend.

Ruminating on appetite and digestion

  • Fiber and polyphenols also help regulate your appetite and calorie intake through the brain.
  • Your microbiome transforms these leftover bioactives into metabolites – molecular byproducts of digestion – that naturally decrease your appetite.

Mitochondrial maestros in the middle

  • Healthy people typically have high-capacity mitochondria that easily process calories to fuel cellular functions.
  • People with metabolic diseases have mitochondria that don’t work as well, contributing to bigger appetites, less muscle and increased fat storage.
  • Your mitochondrial health is ultimately influenced by many factors, including those usually associated with overall well-being: regular exercise, adequate sleep, stress management and healthy eating.

Who turned off the metabo-lights

  • Many bioactives pass undigested through the small intestine to the large intestine, where the microbiome converts them into activated metabolites.
  • When the metabolic “lights” are turned on, they enliven the mitochondria responsible for a faster metabolism, effectively increasing the calories you use.

Please mind the microbiome gap

  • Overuse of antibiotics, high stress and lack of exercise can also adversely affect microbiome and mitochondrial health.
  • This creates a double nutrition gap: a lack of healthy diet and a deficiency in the microbes to convert its bioactives.
  • Emerging microbiome-targeting approaches might also prove helpful for improving your metabolic health: butyrate and other postbiotics to provide preformed microbiome metabolites, personalized nutrition to tailor your diet to your microbiome, intermittent fasting to help repair your microbiome, and the future possibility of live bacterial therapies to restore microbiome health.

Tools to transform fat into fuel

The fascinating secrets of plant reproduction that scientists are still uncovering

Retrieved on: 
Tuesday, September 10, 2024

Just like animals, flowering plants engage in sexual reproduction where male and female parts come together and create new life.

Key Points: 
  • Just like animals, flowering plants engage in sexual reproduction where male and female parts come together and create new life.
  • A step change in research is shaking up the way scientists think about plants: they are far more complex and more like us than you might imagine.
  • This blossoming field of science is too delightful to do it justice in one or two stories.
  • This article is part of a series, Plant Curious, exploring scientific studies that challenge the way you view plantlife.
  • In mammal reproduction, the sperm are highly mobile, and many arrive at the egg around the same time.
  • To avoid these issues, around 50% of flowering plant species have developed a mechanism called self-incompatibility, which helps to prevent inbreeding.
  • But every year scientists are learning more about how intricate and complex their lives are.